Researchers from Leiden University, University of York, University of Barcelona/IQTCUB/ICREA and The Francis Crick Institute ...

Researchers from the University of Barcelona, Leiden University (Netherlands) and the University of York and the Francis Crick Institute (United ...

Aims In this study, we analyze the challenges involved in detecting novel neuraminidase inhibitors (NAIs) and offer strategies to overcome them with complementary bioassays. Materials & Methods We ...

With avian influenza A (H5N1) infecting more mammals than ever before -- including U.S. dairy cattle-- infectious disease experts are paying close attention to whether current influenza antivirals ...

Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current antiviral therapies, such as neuraminidase inhibitors and ...

CD388 is an investigational drug-Fc conjugate that combines zanamivir, a neuraminidase inhibitor, with a human antibody fragment. The Food and Drug Administration (FDA) has granted Breakthrough ...

Human parainfluenza viruses are a major cause of respiratory infections that particularly affect young children and immunocompromised individuals. These viruses present a significant global health ...

Tamiflu, the same antiviral used to treat ordinary seasonal influenza, is the front line medication recommended for treating highly pathogenic bird flu (Photo by Rui Vieira/PA Images via Getty Images) ...